Shares Of Regulus Therapeutics Inc. Tumble After CEO Departure

Yesterday's shares of Regulus Therapeutics Inc. dropped 16% after the company reported departure of the CEO and President. There is good reason for investors to worry for this sudden departure right before announcement of major results.